Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Invested Capital (2016 - 2025)

Vycor Medical has reported Invested Capital over the past 16 years, most recently at -$4.1 million for Q4 2025.

  • Quarterly Invested Capital fell 10.75% to -$4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Dec 2025, down 10.75% year-over-year, with the annual reading at -$4.1 million for FY2025, 10.75% down from the prior year.
  • Invested Capital was -$4.1 million for Q4 2025 at Vycor Medical, down from -$4.0 million in the prior quarter.
  • Over five years, Invested Capital peaked at $2.4 million in Q4 2021 and troughed at -$4.1 million in Q4 2025.
  • The 5-year median for Invested Capital is -$3.2 million (2023), against an average of -$2.9 million.
  • The largest YoY upside for Invested Capital was 220.89% in 2021 against a maximum downside of 435.48% in 2021.
  • A 5-year view of Invested Capital shows it stood at $2.4 million in 2021, then tumbled by 222.78% to -$2.9 million in 2022, then decreased by 13.08% to -$3.3 million in 2023, then dropped by 10.96% to -$3.7 million in 2024, then decreased by 10.75% to -$4.1 million in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Invested Capital are -$4.1 million (Q4 2025), -$4.0 million (Q3 2025), and -$3.9 million (Q2 2025).